SNSE Form 144: 950 Shares Listed for Sale

James Peyer filed a Form 144 reporting a proposed sale of 950 common shares on 02/18/2026.

Rhea-AI Filing Summary

James Peyer filed a Form 144 reporting a proposed sale of 950 common shares on 02/18/2026. The filing lists the sale as an option granted 06/11/2024 and names Fidelity Brokerage Services LLC as the broker. The excerpt also shows prior sales of 841 common shares on 12/09/2025 for $6,706.72.

Insights

Securities Compliance Counsel

Form 144 notifies of an intended Rule 144 sale of 950 common shares by a reporting party.

The filing lists a proposed sale of 950 common shares with the sale method described as cash and lists Fidelity Brokerage Services LLC as broker on 02/18/2026. The entry notes the underlying grant date as 06/11/2024.

Also disclosed: prior sales of 841 common shares on 12/09/2025 for $6,706.72. Timing and final execution depend on holder action; cash‑flow recipient and additional transaction details are contained in the filing lines shown.

FAQ

What does the SNSE Form 144 filing disclose?

It discloses a planned sale of 950 common shares on 02/18/2026. The filing shows the sale tied to an option granted on 06/11/2024, names Fidelity Brokerage Services LLC as broker, and notes cash as the sale method.

Who is listed as the selling party in the SNSE excerpt?

James Peyer is identified in the filing excerpt. The excerpt lists James Peyer’s address and prior sales activity, and separately names Fidelity Brokerage Services LLC as the broker handling the listed sale.

How many shares were previously sold by the reporting party?

The excerpt shows prior sales of 841 common shares on 12/09/2025. The filing also records proceeds of $6,706.72 associated with that prior sale, as presented in the excerpt lines.

What sale method and proceeds are shown in the filing?

The planned sale is listed as for cash on 02/18/2026. The excerpt labels the current sale method as Cash; prior sales show proceeds of $6,706.72 for 841 shares on 12/09/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 01:22 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001843594
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Sensei Biotherapeutics, Inc.
SEC File Number	001-39980
Address of Issuer	1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MARYLAND 20850
Phone	(240) 243-8000
Name of Person for Whose Account the Securities are To Be Sold	Peyer James
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Fomer Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	950	25769.19	1261290	02/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/18/2026	Option Granted 06/11/2024	Issuer			950	02/18/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Peyer 1405 Research Blvd Suite 125 Rockville MD 20850	Common	12/09/2025	841	6706.72

144: Remarks and Signature

Remarks
Date of Notice	02/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James Peyer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)